Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1Breast 1

Conditions

Multiple Myeloma 11Lymphoma, Non-Hodgkin 9Lymphoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myeloid, Acute 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Myelodysplastic Syndromes 4Neoplasms, Plasma Cell 3Melanoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia 3Glioma 3Carcinoma, Non-Small-Cell Lung 3Primary Myelofibrosis 2Ovarian Neoplasms 2Myeloproliferative Disorders 2Lymphoma, B-Cell 2Immunoglobulin Light-chain Amyloidosis 2Hematologic Neoplasms 2Glioblastoma 2Burkitt Lymphoma 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Solid Tumor 1Sarcoma 1Recurrence 1Philadelphia Chromosome 1Pancreatic Neoplasms 1Osteosarcoma 1

Interventions

Trastuzumab 628Paclitaxel 577Cyclophosphamide 555Docetaxel 485Capecitabine 401Letrozole 376Fulvestrant 327Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 186Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 138Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Blood Component Removal × Clear all
NCT00001832 2012-12-21

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
170 enrolled 23 charts
BreastDermatologic

Breast Neoplasms, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡